Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Danaher"


25 mentions found


A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. Catalent named three pharma industry executives and a senior Elliott executive to its board and said John Greisch, who has served on the board since 2018, will become executive chairman. Elliott, whose stake in Catalent became public last month, has been engaging with the company behind the scenes for months. Two of the directors were picked by Elliott, while two were mutually agreed by Elliott and Catalent. Catalent is also forming a new strategic and operational review committee which Greisch will chair.
Persons: Yves Herman, Elliott, Catalent, Alessandro Maselli, John Greisch, Max, William Blair, Maselli, Steven Barg, Goldman Sachs, Frank D'Amelio, Stephanie Okey, Michelle Ryan, Greisch, Merck KGaA, Svea Herbst, Bayliss, Maggie Fick, Sriparna Roy, Shinjini Ganguli, Catherine Evans, Mike Harrison Organizations: REUTERS, Catalent Inc, Elliott Investment Management, Reuters, Novo, pharma, U.S . Food, Drug Administration, Pfizer, Johnson, Catalent, Svea, Thomson Locations: Brussels, Belgium, ., Danish, Novo, United States, Catalent, GLP, Boston, London, Bengaluru
Oracle (ORCL) upgraded to buy from neutral at UBS with a price target of $140. Piper Sandler increases its Broadcom (AVGO) price target to $925 from $830 ahead of earnings Thursday after the bell. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: telco, Corie Barry, Piper Sandler, Bernstein, Jim Cramer's, Jim Cramer, Jim, Marlena Sloss Organizations: Oracle, UBS, Nvidia, Investing, Nasdaq, Verizon, Citi, underperform, Biden Administration, Medicare, pharma, DuPont, Broadcom, Jim Cramer's Charitable, CNBC, Bloomberg, Getty Locations: Airbnb, Salesforce, San Francisco , California
A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. The sources declined to be identified because the information is confidential and cautioned a deal could still collapse at the last minute. Spokespeople for Catalent and Elliott declined to comment. In the past when Elliott has pushed for sales of pieces or the entire target company, including at eBay and Switch Inc., and then won board representation, significant ownership changes have followed. Novo Nordisk's weight-loss drug Wegovy is filled by Catalent’s Brussels factory and last week Reuters reported that Catalent’s plant in Bloomington, Indiana will begin filling Wegovy injection pens for Novo.
Persons: Yves Herman Acquire, Elliott, Catalent, Elliott isn't, Keith Meister's, Scott Ferguson's, Mauricio Gutierrez, Svea Herbst, Bayliss, Maggie Fick, Shri Navaratnam Organizations: REUTERS, Catalent, Elliott Investment Management, AstraZeneca, Johnson, Moderna, eBay, Inc, Deutsche Bank, Management, Capital Management, Reuters, NRG, Svea, Thomson Locations: Brussels, Belgium, U.S, Bloomington , Indiana, Novo, Boston, London
Medical tech firm Danaher to buy Abcam in $5.7 bln deal
  + stars: | 2023-08-28 | by ( ) www.reuters.com   time to read: +2 min
Aug 28 (Reuters) - Danaher Corp (DHR.N) said on Monday it would buy smaller rival Abcam Plc in an all-cash deal valued at $5.7 billion including debt, as the medical tools supplier expands its services to capture bigger contracts. The deal will help Danaher cushion the hit from sluggish demand for its products such as antibodies and sample preparation equipment from smaller biotech companies that are grappling with a funding crunch. Danaher, one of the world's largest suppliers of medical tools, has already cut its annual sales growth forecast multiple times this year. "This is a nice tuck in deal for Danaher that checks all the boxes. Reuters reported on Friday that Danaher was in the lead to acquire Abcam.
Persons: Vijay Kumar, Danaher, Jonathan Milner, Manas Mishra, Shounak Dasgupta, Sriraj Organizations: Danaher, Abcam Plc, Reuters, Bloomberg, Electric, Thomson Locations: Cambridge, England, Bengaluru
A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. Spokespeople for Catalent and Elliott declined to comment. The U.S.-based contract drugmaker is also Danish company Novo Nordisk's (NOVOb.CO) main manufacturing partner for its popular weight-loss drug Wegovy. The volatility at Catalent could increase scrutiny on the relationship between Novo and its partner. Reuters reported last week that a second Catalent factory will begin filling Wegovy injection pens for Novo as part of an expanded supply agreement.
Persons: Yves Herman Acquire, Elliott, drugmaker, Markus Manns, Catalent, Elliott isn't, Keith Meister's, Scott Ferguson's, Mauricio Gutierrez, Svea Herbst, Bayliss, Maggie Fick, Amanda Cooper, Shri Navaratnam, Bernadette Baum, Catherine Evans Organizations: REUTERS, Elliott Investment Management, Catalent, Novo, Reuters, Union Investment, AstraZeneca, Johnson, Moderna, eBay, Inc, Deutsche Bank, Management, Capital Management, NRG, Svea, Thomson Locations: Brussels, Belgium, U.S, Danish, Novo, United States, Germany, Boston, London
US imports from China are down this year, and direct investment in China is a sliver of the US GDP. However, William Lee, the Milken Institute's chief economist, told Insider China's economic stumble might not be all bad for the US. Meanwhile, Chinese imports of US goods, which may continue to slow, amounted to less than 1% of the US GDP, suggesting a reduction in Chinese imports wouldn't drastically harm the US economy. In addition, China's slowing economy has already chipped away at some American companies' revenues, including DuPont's and Danaher's. AdvertisementAdvertisementThough China's economy has been plagued by a number of crises, including low consumer confidence, many Americans may not have to worry about the downturn hurting their wallets.
Persons: Joe Biden, Janet Yellen, William Lee, Milken, Lee, Paul Krugman, , Luis Torres, it's Organizations: Service, Milken Institute's, US, New York Times, Commerce Department, Federal Reserve, Bank of England, European Central Bank, Federal Reserve Bank of Dallas Locations: China, Wall, Silicon, United States, Ukraine, Russia, Europe, Vietnam, India, Mexico, Hong Kong, Canada, American
Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. Equities rise Watch Danaher's portfolio A flurry of trades 1. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: Jim Cramer, Jerome Powell's, Danaher, Estee Lauder, Walt Disney, Jim Cramer's, Jim Organizations: CNBC, Federal, Treasury, West Texas, Micro Devices, Broadcom, GE HealthCare Technologies, Starbucks, Jim Cramer's Charitable Locations: Jackson Hole , Wyoming, Danaher
Xpeng — U.S.-traded shares of the Chinese electric vehicles company jumped 5% Monday premarket. Xpeng announced it would buy Didi's smart electric car business in a deal worth $744 million. Mister Car Wash — The car wash stock climbed 5.7% in premarket trading following an upgrade to overweight from neutral by Piper Sandler. The firm said Mister Car Wash has upside potential over the next two years. CrowdStrike — Shares of the cybersecurity company fell 2.6% in premarket trading after Morgan Stanley downgraded CrowdStrike to equal weight from overweight.
Persons: Xpeng, Piper Sandler, CrowdStrike, Morgan Stanley, Akero, Conor Flynn, Danaher, , Jesse Pound, Sarah Min, Alexander Harring Organizations: Shanghai International Automobile Industry, National Exhibition, Convention Center, , Bloomberg News, UBS, RPT, Kimco Realty, Boston, Boston Scientific Locations: Shanghai, China, Xpeng —
Monday Monday proved to be a harbinger for the rest of the week, beginning with purchases of GE Healthcare (GEHC) and Stanley Black & Decker (SWK). GE Healthcare and Stanley Black & Decker appeared especially attractive, leading us to buy 100 shares and 150 shares, respectively. For GEHC, we wanted to take advantage of what we believe was an unwarranted decline in the medical technology company's stock price. Our purchase of Starbucks represents another buying-into-post-earnings-weakness situation, as we did with Microsoft and Stanley Black & Decker earlier in the week. That's why on Thursday we took our Nvidia price target to $600 per share from $450, implying roughly 27% upside.
Persons: Jerome Powell's Jackson, Here's, Stanley Black, Decker, SWK, Nikesh Arora, Jim Cramer, that's, Locker, Locker's, , Jim Cramer's, Jim, Angela Weiss Organizations: Federal, GE Healthcare, Microsoft, Palo Alto Networks, Big Tech, Amazon, Starbucks, Broadcom, Devices, Nvidia, Charitable, AMD, CNBC, Traders, New York Stock Exchange, AFP, Getty Locations: Danaher, New York City
Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. Watch Emerson Electric JPMorgan on Tuesday upgraded Emerson Electric (EMR) to overweight, or buy, form hold. Still, Jim Cramer said Tuesday that the company is "not managed the way I like it to be." As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .
Persons: Jim Cramer, it's, Emerson, Jim, We'll, Mary Dillon, Jim Cramer's Organizations: CNBC, Watch Emerson, Nasdaq, Treasury, West Texas, Watch Emerson Electric JPMorgan, Emerson, JPMorgan, National Instruments, Sporting, Club, Nvidia Locations: Danaher
We are buying 25 shares of Danaher (DHR), at roughly $250.48 apiece. Following Tuesday's trade, Jim Cramer's Charitable Trust will be own 520 shares of DHR, increasing its weighting in the portfolio to 4.58% from 4.37%. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: Jim Cramer's, Danaher, Jim Cramer, Stanley Black, Decker, we've, GEHC, Jim, Science REIT, Geno Organizations: DHR, DuPont de Nemours, Honeywell, GE HealthCare, CNBC, Science Locations: Danaher
China's slowing economy is chipping away at some American companies' revenues. China's July economic report didn't mention youth-unemployment statistics after it soared to 21.3% in the second quarter, citing economic and social changes. While Chinese manufacturing and construction are struggling to recover, some American companies with strong ties to China are also feeling the effects. Dow's rival DuPont also reported a drop in China sales from existing operations, a 14% year-over-year fall. To be sure, some American companies have performed well in China over the past few months.
Persons: Gamble, Stephen Williamson, Danaher, Rainer Blair, Howard Ungerleider, Edward Breen, Marriott Organizations: DuPont, Danaher, Procter, Service, Citigroup, Intel, Toyota, Nissan, Apple, Starbucks, Street Journal, Monetary Fund Locations: China, Wall, Silicon, American, Ohio, Greater China, Beijing
There are five stocks I would buy right now if I were just joining the Club, or had come into some new money. And Dupont has a ton of cash to buy back stock while it happens. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.
Persons: Jerome Powell, Powell, Ed Breen, Dupont, Danaher, Eli Lilly, Vimal Kapur, Stanley Black, Decker, Jim Cramer's, Jim Cramer, Jim, Al Drago Organizations: Club, DuPont de Nemours, GE HealthCare, Honeywell, Boeing, General Electric, GE, Airbus, SWK, CNBC, US Federal Reserve, Market, Bloomberg, Getty Locations: GEHC, Washington , DC
Here's a rapid-fire update on all 36 stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. Apple remains an "own it, don't trade it" stock, Jim said. Halliburton (HAL): Given we just added a new stock to the portfolio, Jim said Halliburton may be the stock we look to cut ties with. The lesson with P & G is that, sometimes, there's nothing to do but hold a stock, Jim said. Stanley Black & Decker (SWK): The maker of DeWalt and Craftsman tools is one of the best bargains in our portfolio, Jim said.
Persons: Jim Cramer's, Jim, it's, We're, , he's, he'll, we're, Dupont, Walt Disney, Estee Lauder, Locker, Mary Dillon's, Halliburton, Humana, Humana's, Linde, Eli Lilly, there's, Mark Zuckerberg's, Jim said, Morgan Stanley, James Gorman, Nikesh Arora, Elliott Management's, Elliott, Stanley Black, Decker, It's, Wells Fargo, Wells, Charlie Scharf —, Jim Cramer, Jim Cramer Rob Kim Organizations: Jim Cramer's Charitable Trust, CNBC, Club, Apple, Devices, AMD, Nvidia, Amazon, Federal, Bausch Health, Caterpillar, Costco, Coterra Energy, DuPont de Nemours, Comcast, Emerson, Emerson Electric, Ford, United Auto Workers, GE HealthCare Technologies, Big Tech, NFL, Halliburton, HAL, Texas, Honeywell International, Honeywell, Linde, LIN, Facebook, Reality Labs, Microsoft, Oracle, Palo Alto Networks, Procter & Gamble, Natural Resources, Starbucks, Constellation Brands, TJX, Goods, Wynn Resorts, WYNN, Jim Cramer's Charitable Locations: Bausch, China, Hulu, NBCUniversal, Palo, Macao
Aug 9 (Reuters) - Charles River Laboratories International (CRL.N) beat Wall Street estimates for second-quarter results on Wednesday, as the strong demand for contract researcher's tools and services cushioned the impact of suspended non-human primates' (NHP) shipment. The statement comes after Charles River in February suspended the shipment of NHPs from Cambodia as the Department of Justice and U.S. Fish and Wildlife Service investigated the company over smuggling of wild long-tailed macaques to the United States. The Massachusetts-based company tightened its full-year profit forecast to the range of $10.30 to $10.90 per share, compared with $9.90 to $10.90 previously expected. Excluding items, the company earned $2.69 per share in the quarter ended July 1, beating analysts' average estimate of $2.64 per share.
Persons: Charles River, Charles River's, Vaibhav Sadhamta, Shweta Agarwal Organizations: River Laboratories, Department of Justice, Fish, Wildlife Service, Thomson Locations: United States, NHPs, Cambodia, The Massachusetts
Meanwhile, S & P 500 companies are spending more and more on capital expenditures (CapEx). Certainly, some companies execute wise buybacks, while others are not as ideal. Humana repurchased $529 million worth of common stock in the second quarter, after spending only $4 million in the year-ago period. Of course, companies also must consider their spending on buybacks versus investments back in the business in order to support growth, such as new manufacturing equipment or data centers. But less spending on buybacks is not necessarily something to worry about.
Persons: BofA, Savita Subramanian, Wells, Wells Fargo, Caterpillar Morgan Stanley, Halliburton Emerson, Eli Lilly, Emerson, we've, It's, Jim Cramer's, Jim Cramer, Jim, Spencer Platt Organizations: of America, GE Healthcare, Caterpillar, Humana, Halliburton, HAL, Humana . Halliburton, Bank, Microsoft, Linde, LIN, Natural Resources, Honeywell, Halliburton Emerson Electric, Ford, Procter, Gamble, Coterra, Bank of America, Bank of, Jim Cramer's Charitable, CNBC, Getty Locations: U.S, Wells Fargo, Wells
Elon Musk said he can't confirm a date for his fight with Mark Zuckerberg just yet. Musk said he's getting an MRI of his neck and back, and may even require surgery before the fight. It looks like that cage match isn't going to happen anytime soon if Musk's got to go under the knife. Musk's neck and back issues could be linked to a sumo match he once participated in. Musk did not specify when this sumo match took place.
Persons: Elon Musk, Mark Zuckerberg, Musk, Musk's, Elon, Zuckerberg, Georges St, Pierre, Lex Fridman, John Danaher, he's, hasn't Organizations: Twitter, Canadian UFC
His flagship Third Point hedge fund is lagging the broad market by 20%. Third Point's flagship offshore fund was up only 1.1% in the second quarter, bringing its 2023 loss to 3%, according to his latest investor letter. "Managers who have had less than 25% of their funds in these stocks have found it challenging to keep up with 'the market,'" Loeb told his investors. The Russell 1000 Growth index is up nearly 30% this year, whereas its value counterpart has gained only 6%. The hedge fund manager revealed his biggest losers this year included Alibaba , Danaher, Catalent and International Flavors & Fragrances .
Persons: Dan Loeb, That's, he's, Loeb, Russell, Alibaba Organizations: Microsoft, Nvidia, Apple, AMD, Google
A handful of the most well-known technology stocks are being somewhat ignored by socially conscious funds, according to Bernstein. Big technology names including Apple , Amazon , Meta , Microsoft and Alphabet were among the most underweighted stocks by North American funds that consider environmental, social and corporate governance factors when screening investment ideas. Big Tech has roared back to life this year, coming off 2022's selloff as investors bet on a better interest rate environment. Here are the 10 most underweighted stocks by North American funds: On the flip side, a wide swath of stocks accounted for the most held, relatively. Barclays analyst Craig Rye said the stock could actually benefit if hurricane season is worse than was previously expected.
Persons: Bernstein, Danaher, Craig Rye, Rye, , Michael Bloom Organizations: Apple, Meta, Microsoft, North, Big Tech, Software, Nvidia, Insurance, Barclays, Fisher, Deere
SALT brings together public policy officials, capital allocators, and hedge fund managers to discuss financial markets. REUTERS/Steve MarcusLONDON, Aug 1 (Reuters) - Billionaire investor Daniel Loeb has reduced the size of short bets on single named companies to limit the vulnerability of his hedge fund, Third Point, to short squeezes, he said in a letter on Tuesday. "The short-selling environment is much more challenging than it has been historically," said Loeb in the letter. Almost half of Loeb's net long exposure includes companies that will benefit from developments in artificial intelligence, the letter said. Elsewhere at Third Point, Loeb's corporate credit team returned a net 8.7% for the quarter after market instability in the March banking crisis created opportunities for the fund, Loeb said.
Persons: Daniel S, Loeb, Steve Marcus LONDON, Daniel Loeb, Ferguson, Nell Mackenzie, Amanda Cooper Organizations: Third, REUTERS, Pacific Gas and, Microsoft, HK, Offshore Fund, Web Services, Google, Thomson Locations: Las Vegas , Nevada, allocators
Look beyond tech But there are opportunities beyond tech: Morningstar data reveals the funds outside of tech and growth sectors that have also outperformed over the last five years. Top holdings include Home Depot, Johnson Controls International, Floor & Décor and Trane Technologies. Guinness Atkinson Alternative Energy Fund : This fund picks companies in the alternative energy sector, with at least half of the business dedicated to renewable energy or energy efficiency. Global X Lithium and Battery Tech ETF : The ETF comprises lithium producers and lithium battery makers — all essential to electric vehicles. Top holdings include United Airlines, Marathon Oil, Tyson Foods, Best Buy, and Synchrony Financial.
Persons: James Demmert, Hubbell, MasTec, Invesco Russell, Russell, Vanguard Baillie Gifford Organizations: Street Research, U.S . Federal, Morningstar, Enphase Energy, Fidelity, Housing, Home, Johnson, Trane Technologies, Guinness Atkinson Alternative Energy Fund, Schneider, NextEra Energy, Shelton Sustainable Equity Fund, Bunge, Battery Tech ETF, Samsung SDI, Trust, Industrial Renaissance, SPX Technologies, Sterling Infrastructure, Global, U.S . Infrastructure Development, Holdings, Rockwell Automation, United Rentals, Deere, Co, United Airlines, Marathon Oil, Tyson Foods, Synchrony, Heptagon, Equity Fund, Xenon Pharmaceuticals, TransMedics, FTAI Aviation, Vanguard, Moderna, Alnylam Pharmaceuticals, Coursera, Water Resources, Nasdaq, Water Locations: Luxembourg, Eaton, Albemarle
General Motors — Shares of General Motors rose more than 1% after the automaker raised its full-year guidance and reported second-quarter results that rose on a year-over-year basis. 3M posted $7.99 billion in revenue, beating analysts' estimates of $7.87 billion, according to Refinitiv. The company also raised its full-year earnings guidance and reaffirmed its revenue guidance. The airline's full-year earnings guidance of $5.50 to $7.50 per share was roughly in-line with the average analyst estimates of $6.65, according to FactSet. Verizon — The telecommunications giant traded 2.6% higher after reaffirming its full-year guidance.
Persons: Danaher, FactSet, Lilium, Refinitiv, Piper Sandler, Edward Yruma, , Samantha Subin, Yun Li, Jesse Pound, Sarah Min, Tanaya Macheel Organizations: General Motors, Xerox, FactSet, General, GE, Spotify, European Union Aviation Safety Agency, Alaska Air, Raytheon, Refinitiv, Verizon, Walmart Locations: Alaska
Life sciences and medical diagnostics company Danaher (DHR) delivered a second-quarter earnings beat on Tuesday, but lowered its outlook for the year. When excluding the impact of Covid-related tests and products, Danaher realized base-business core sales growth of 2%. As a result, management was once again forced to downwardly revise their sales growth outlook for the year. We predict a bioprocessing bottom this year, early next year at the very latest, setting us for a rebound in organic revenue growth. This updated outlook represents a downward revision from the high-single-digit percentage decline previously expected on a core basis and the mid-single-digit percentage growth previously expected for the base business.
Persons: Danaher, Cash, Bioprocessing, That's, Sartorius, Cepheid, Jim Cramer's, Jim Cramer, Jim, Marisol Darge, Robert McCabe, Hyoung Chang Organizations: Revenue, Management, Wall, Biotechnology, pharma, CNBC, Kaiser Permanente Arapahoe Medical, Getty Locations: DHR, China, Base, Centennial , Colorado, Denver
A look at the day ahead in European and global markets from Tom WestbrookEarnings and hope for a turning in China's markets are the prelude to this week's big central bank decisions. The corporate performance and outlook risk disappointing markets that are increasingly priced for a "soft-landing" slowdown in both growth and inflation. In the Asia session investors cheered pledges of support in the readout from an earlier-than-expected Politburo meeting in China -- though not too loudly. The Eurozone bank lending survey is also out on Tuesday and can give a view on the health of borrowing ahead of Fed and European Central Bank meetings, which are both expected to deliver rate hikes. The yen was steady in Asia as investors weigh whether the Bank of Japan will tweak policy on Friday.
Persons: Tom Westbrook, Robert Half, Archer, Daniel Midlands, Morgan Stanley, Dalian Wanda, Sam Holmes Organizations: Microsoft, Google, Visa, General Electric, Dow, chipmaker Texas, Unilever, Shanghai, Traders, Dalian, Fed, European Central Bank, Bank of Japan, EssilorLuxottica, Texas Instruments, Verizon, General Motors, ADM, Spotify, Thomson Locations: United States, London, Paris, Asia, China, Hong Kong
Biotech’s doldrums are a warning amid exuberance
  + stars: | 2023-07-25 | by ( ) www.reuters.com   time to read: +2 min
The sector’s doldrums are a warning sign, despite the broader market shrugging off recession concerns. In 2000, the index peaked weeks before the S&P 500 Index (.SPX) and hit bottom three months earlier. In the 2009 financial crisis, the biotech index peaked later, but both emerged at about the same time. Yet biotech stocks have been lackluster since. Since January, the index is down 2%, while the S&P 500 Index is up 19% and the Nasdaq Composite Index is up 35%.
Persons: Robert Cyran, Jonathan Guilford, Sharon Lam Organizations: YORK, Reuters, Biotechnology, Nasdaq Biotechnology, Nasdaq, Twitter, Thales, Thomson Locations: Spain
Total: 25